Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 2154-2160

  Lonze, B E ^a   Dagher, N N ^a   Simpkins, C E ^a   Locke, J E ^a   Singer, A L ^a   Segev, D L ^a   Zachary, A A ^a   Montgomery, R A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; paired kidney donation; proteasome inhibitors; sensitized transplant recipient

Indexed keywords

BORTEZOMIB; CREATININE; DEXAMETHASONE; ECULIZUMAB; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; GENOTYPE; HEMODIALYSIS; HLA MATCHING; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; SKIN GRAFT; SUPERIOR MESENTERIC VEIN; T LYMPHOCYTE; VEIN THROMBOSIS;

ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; BORONIC ACIDS; CATHETERS, INDWELLING; CREATININE; DESENSITIZATION, IMMUNOLOGIC; DRAINAGE; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL VEIN; HUMANS; ILIAC VEIN; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; PROTEASE INHIBITORS; PYRAZINES; SPLANCHNIC CIRCULATION; THERAPIES, INVESTIGATIONAL; TISSUE AND ORGAN PROCUREMENT; VENA CAVA, INFERIOR; VENA CAVA, SUPERIOR; VENOUS THROMBOSIS;

EID: 77956133521     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03191.x     Document Type: Article

References (20)

1. UNOS. Organ Procurement and Transplantation Network Data as of December 22, 2009. Available from : http://www.unos.org.
2. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
3. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002 2 : 758 760.
4. Vo AA, Lukovsky M, Toyoda M et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008 359 : 242 251.
5. Montgomery RA, Zachary AA, Ratner LE et al. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005 294 : 1655 1663.
6. Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005 293 : 1883 1890.
7. Montgomery RA, Gentry SE, Marks WH et al. Domino paired kidney donation: A strategy to make best use of live non-directed donation. Lancet 2006 368 : 419 421.
8. Rees MA, Kopke JE, Pelletier RP et al. A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med 2009 360 : 1096 1101.
9. de Klerk M, Keizer KM, Claas FH, Witvliet M, Haase-Kromwijk BJ, Weimar W. The Dutch national living donor kidney exchange program. Am J Transplant 2005 5 : 2302 2305.
10. Segev DL, Kucirka LM, Gentry SE, Montgomery RA. Utilization and outcomes of kidney paired donation in the United States. Transplantation 2008 86 : 502 510.
11. Stavropoulos SW, Pan JJ, Clark TW et al. Percutaneous transhepatic venous access for hemodialysis. J Vasc Interv Radiol 2003 14 (9 Pt 1 1187 1190.
12. Funaki B, Zaleski GX, Leef JA, Lorenz JN, Van Ha T, Rosenblum JD. Radiologic placement of tunneled hemodialysis catheters in occluded neck, chest, or small thyrocervical collateral veins in central venous occlusion. Radiology 2001 218 : 471 476.
13. Wong JJ, Kinney TB. Azygos tip placement for hemodialysis catheters in patients with superior vena cava occlusion. Cardiovasc Intervent Radiol 2006 29 : 143 146.
14. Jordan SC, Tyan D, Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial. J Am Soc Nephrol 2004 15 : 3256 3262.
15. Wu J. On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants. Am J Transplant 2002 2 : 904 912.
16. Curran MP, McKeage K. Bortezomib: A review of its use in patients with multiple myeloma. Drugs 2009 69 : 859 888.
17. Everly MJ, Everly JJ, Susskind B et al. Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection. Transplantation 2008 86 : 1754 1761.
18. Hillmen P, Hall C, Marsh JC et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2004 350 : 552 559.
19. Locke JE, Magro CM, Singer AL et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant 2009 9 : 231 235.
20. Stegall MD, Diwan TS, Burns JM et al. Prevention of acute humoral rejection with C5 inhibition. Am J Transplant 2009 9 : 241 (abstract No.178).